Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - CUMBERLAND PHARMACEUTICALS INC | g26446e10vk.htm |
| EX-31.2 - EX-31.2 - CUMBERLAND PHARMACEUTICALS INC | g26446exv31w2.htm |
| EX-32.1 - EX-32.1 - CUMBERLAND PHARMACEUTICALS INC | g26446exv32w1.htm |
| EX-31.1 - EX-31.1 - CUMBERLAND PHARMACEUTICALS INC | g26446exv31w1.htm |
| EX-10.13 - EX-10.13 - CUMBERLAND PHARMACEUTICALS INC | g26446exv10w13.htm |
| EX-10.12 - EX-10.12 - CUMBERLAND PHARMACEUTICALS INC | g26446exv10w12.htm |
| EX-10.26 - EX-10.26 - CUMBERLAND PHARMACEUTICALS INC | g26446exv10w26.htm |
| EX-10.15 - EX-10.15 - CUMBERLAND PHARMACEUTICALS INC | g26446exv10w15.htm |
| EX-10.11 - EX-10.11 - CUMBERLAND PHARMACEUTICALS INC | g26446exv10w11.htm |
Exhibit 23.1
Consent
of Independent Registered Public Accounting Firm
The Board of Directors
Cumberland Pharmaceuticals Inc.:
We consent to the incorporation by reference in the registration
statement
No. 333-164376
on
Form S-8
of Cumberland Pharmaceuticals Inc. of our report dated
March 11, 2011, with respect to the consolidated balance
sheets of Cumberland Pharmaceuticals Inc. and subsidiaries as of
December 31, 2010 and 2009, and the related consolidated
statements of income, cash flows, and equity and comprehensive
income for each of the years in the three-year period ended
December 31, 2010, the related financial statement
schedule, and the effectiveness of internal control over
financial reporting as of December 31, 2010, which reports
appear in the December 31, 2010 annual report on
Form 10-K
of Cumberland Pharmaceuticals Inc.
/s/ KPMG
LLP
Nashville, Tennessee
March 11, 2011